Genetic variation associated with condensate dysregulation in disease is a research paper published in Developmental Cell (2022). On theSindex it has a DataRank of 0. It has been cited 105 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Science Foundation
Grant: 2 R01 MH104610-20
National Science Foundation
Grant: PHY1743900
National Institutes of Health
Grant: R01 GM123511
U.S. Department of Defense
Grant: W81XWH-20-10716
National Cancer Institute
Grant: F32 1F32CA254216
National Cancer Institute
Grant: F31 CA250171
National Cancer Institute
Grant: T32 CA251062-02
NCI NIH HHS
Grant: P01 CA155258
NIGMS NIH HHS
Grant: T32 GM087237
NIMH NIH HHS
Grant: R01 MH104610
NCI NIH HHS
Grant: T32 CA251062
NIDDK NIH HHS
Grant: T32 DK007191
NCI NIH HHS
Grant: F32 CA254216
National Institutes of Health
Grant: 5R01GM123511-15
Transcriptional regulatory networks in living cells
National Institutes of Health
Grant: 5F31CA250171-02
Characterizing the Physicochemical Properties of Estrogen Receptor-mediated Transcriptional Condensates in Breast Cancer
National Institutes of Health
Grant: 5T32DK007191-45
Research Training in Digestive Diseases
National Institutes of Health
Grant: 5F32CA254216-03
RNA-mediated Feedback Control of Oncogenic Transcription
National Institutes of Health
Grant: 1T32CA251062-01
Oncopathology Training Program
National Institutes of Health
Grant: 5R01MH104610-19
Genetically engineered human pluripotent stem cells as a platform to define the b
National Science Foundation
Grant: 1743900
RAISE: A Phase Separation Model for Transcriptional Control in Mammals
Hope Funds for Cancer Research
Novo Nordisk
FWCI
8.15
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Phase separation as a possible mechanism for dosage sensitivity
Additional file 1 of Phase separation as a possible mechanism for dosage sensitivity
Additional file 9 of Phase separation as a possible mechanism for dosage sensitivity
Additional file 9 of Phase separation as a possible mechanism for dosage sensitivity
Additional file 6 of Phase separation as a possible mechanism for dosage sensitivity
Additional file 8 of Phase separation as a possible mechanism for dosage sensitivity
Additional file 6 of Phase separation as a possible mechanism for dosage sensitivity
Additional file 7 of Phase separation as a possible mechanism for dosage sensitivity
Additional file 7 of Phase separation as a possible mechanism for dosage sensitivity
Additional file 8 of Phase separation as a possible mechanism for dosage sensitivity
Additional file 5 of Phase separation as a possible mechanism for dosage sensitivity
Additional file 2 of Phase separation as a possible mechanism for dosage sensitivity
Additional file 3 of Phase separation as a possible mechanism for dosage sensitivity
Additional file 4 of Phase separation as a possible mechanism for dosage sensitivity
Additional file 4 of Phase separation as a possible mechanism for dosage sensitivity
Additional file 5 of Phase separation as a possible mechanism for dosage sensitivity
Additional file 2 of Phase separation as a possible mechanism for dosage sensitivity
Additional file 3 of Phase separation as a possible mechanism for dosage sensitivity